Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$6.64 - $8.21 $1,328 - $1,642
-200 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$8.75 - $15.49 $8,750 - $15,490
-1,000 Reduced 83.33%
200 $2,000
Q4 2020

Feb 10, 2021

SELL
$7.11 - $9.99 $3,199 - $4,495
-450 Reduced 27.27%
1,200 $12,000
Q3 2020

Nov 12, 2020

SELL
$7.15 - $8.73 $4,290 - $5,238
-600 Reduced 26.67%
1,650 $12,000
Q2 2020

Aug 14, 2020

SELL
$6.15 - $9.4 $3,997 - $6,110
-650 Reduced 22.41%
2,250 $20,000
Q1 2020

May 18, 2020

BUY
$5.88 - $15.75 $17,052 - $45,675
2,900 New
2,900 $20,000

Others Institutions Holding SLGL

About Sol-Gel Technologies Ltd.


  • Ticker SLGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,129,500
  • Market Cap $10.2M
  • Description
  • Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...
More about SLGL
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.